Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 0.10 GBp
Change Today 0.00 / 0.00%
Volume 0.0
ULT On Other Exchanges
Symbol
Exchange
London
OTC US
As of 12:00 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

ultrasis plc (ULT) Snapshot

Open
0.10 GBp
Previous Close
0.10 GBp
Day High
0.10 GBp
Day Low
0.10 GBp
52 Week High
05/28/14 - 0.90 GBp
52 Week Low
12/3/14 - 0.05 GBp
Market Cap
1.7M
Average Volume 10 Days
0.0
EPS TTM
-0.0007 GBp
Shares Outstanding
1.8B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ULTRASIS PLC (ULT)

Related News

No related news articles were found.

ultrasis plc (ULT) Related Businessweek News

No Related Businessweek News Found

ultrasis plc (ULT) Details

Ultrasis PLC provides technology driven healthcare products and services that help people maintain, regain, and enhance physical, psychological, and social well-being in the United Kingdom and internationally. Its products include Beating the Blues, which provides treatment for depression and anxiety; GetFit Wellness that provides health promotion and management programs to workforce, members, or community; MyBrainSolutions, which delivers employers with confidential wellbeing and performance solutions to their employees; and GetFitHEALTHCOACH, a program for fitness, weight loss, and wellness. The company also offers Calm Workplace, a questionnaire based tool for delivering advice on stress, anxiety, depression, and insomnia; STEP SUCCESS that offers strong wellness strategies to the United Kingdom companies; and UK Health Screening and Screenetics, which provide health and wellbeing services in the field of employee healthcare benefits, such as health screening, EAP, and flu vaccinations for corporate sector, private organizations, and the general public. In addition, it operates Waterloo Health Clinic, which is located in London providing travel health and general health assessment medical facilities; and Joggle, an online activity monitoring platform, as well as owns and manages The Wellness Shop, an online seller of the health and well-being related products. Ultrasis PLC was incorporated in 1981 and is based in Belfast, the United Kingdom.

65 Employees
Last Reported Date: 01/31/15
Founded in 1981

ultrasis plc (ULT) Top Compensated Officers

Interim Executive Chairman and Chief Executiv...
Total Annual Compensation: 150.0K GBP
Executive Director of Finance, Company Secret...
Total Annual Compensation: 18.0K GBP
Compensation as of Fiscal Year 2014.

ultrasis plc (ULT) Key Developments

Ultrasis plc Intends to Amend its Articles of Association

Ultrasis plc intends to amend its articles to include the rights and restrictions attaching to the deferred shares as set out in paragraph 12 of Part I. A copy of the Articles (incorporating the changes proposed in the Notice of General Meeting) may be obtained from the company's registered office.

Ultrasis plc, Annual General Meeting, Apr 14, 2015

Ultrasis plc, Annual General Meeting, Apr 14, 2015., at 11:00 GMT Standard Time. Location: office of finnCap Ltd.

Ultrasis plc, Special/Extraordinary Shareholders Meeting, Apr 14, 2015

Ultrasis plc, Special/Extraordinary Shareholders Meeting, Apr 14, 2015., at 10:00 GMT Standard Time. Location: offices of finnCap Ltd. Agenda: To consider an ordinary resolution to approve the share capital reorganization; to incorporate provisions into the articles to provide for the rights and restrictions attaching to the deferred shares; to approve and ratify the entering into of the documentation relating to the new facility; to approve and ratify the entering into of the subscription agreements; to authorize the directors to allot relevant securities up to an aggregate nominal value of £119,502.48; to approve the Waiver to be granted by the Panel in respect of the Concert Party and any obligation which might arise on the Concert Party under Rule 9 to make a general offer as a result of the Proposals; to approve and ratify the granting of the options to Mr. Smith, Mr. Kershaw and Mr. Bate pursuant to the terms of the share option scheme; and to approve the change of the name of the company to 365 Health Solutions plc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ULT:LN 0.10 GBp 0.00

ULT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ULT.
View Industry Companies
 

Industry Analysis

ULT

Industry Average

Valuation ULT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULTRASIS PLC, please visit www.ultrasis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.